Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Energy delivery devices and methods

a technology of energy delivery and energy, applied in the field of energy delivery devices and methods, can solve the problems of asthma sufferers' difficulty in breathing, high doses of corticosteroid anti-inflammatory drugs that can have serious side effects that require careful management, and difficulty in patient compliance with pharmacologic management, so as to increase the likelihood of each leg flexure and reduce the profile

Inactive Publication Date: 2011-08-11
ASTHMATX
View PDF3 Cites 39 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0015]The present invention includes devices configured to treat the airways or other anatomical structures, and may be especially useful in tortuous anatomy. The devices described herein are configured to treat with uniform or predictable contact (or near contact) between an active element and tissue. Typically, the invention allows this result with little or no effort by a physician. Accordingly, aspects of the invention offer increased effectiveness and efficiency in carrying out a medical procedure. The increases in effectiveness and efficiency may be especially apparent in using devices having relatively longer active end members.
[0017]Variations of the device can include an elongate sheath having a near end, a far end adapted for insertion into the body, and having a flexibility to accommodate navigation through tortuous anatomy, the sheath having a passageway extending therethrough, the passageway having a lubricious layer extending from at least a portion of the near end to the far end of the sheath. Where the shaft is slidably located within the passageway of the sheath.
[0019]As noted below, variations of the device allow for reduce friction between the shaft and sheath to allow relatively low force advancement of a distal end of the shaft out of the far end of the sheath for advancement the energy transfer element.
[0021]One or both of the components may include stops that control flexure length of each leg. Such a design increases the likelihood that the flexure of each leg is unif rm.
[0022]An additional variation of the device includes a catheter for use in tortuous anatomy to deliver energy from a power supply to a body passageway. Such a catheter includes an expandable energy transfer element having a reduced profile for advancement and an expanded profile to contact a surface of the body passageway and an elongate shaft having a near end, a far end adapted for insertion into the body, the expandable energy transfer element coupled to the far end of the shaft, the shaft having a length sufficient to access remote areas in the anatomy. The design of this shaft includes a column strength sufficient to advance the expandable energy transfer element within the anatomy, and a flexibility that permits self-centering of the energy transfer element when expanded to contact the surface of the body passageway.

Problems solved by technology

Asthma is a disease in which (i) bronchoconstriction, (ii) excessive mucus production, and (iii) inflammation and swelling of airways occur, causing widespread but variable airflow obstruction thereby making it difficult for the asthma sufferer to breathe.
High doses of corticosteroid anti-inflammatory drugs can have serious side effects that require careful management.
The difficulty involved in patient compliance with pharmacologic management and the difficulty of avoiding stimulus that triggers asthma are common barriers to successful asthma management.
Current management techniques are neither completely successful nor free from side effects.
Tortuous anatomy also poses challenges when the treatment device requires mechanical actuation of the treatment portion (e.g., expansion of a treatment element at a remote site).
In particular, attempting to actuate a member may be difficult in view of the fact that the force applied at the operator's hand-piece must translate to the distal end of the device.
Accordingly, when energy or force is applied to move two polymers against each other, a significant part of friction between the polymers is the energy loss through inelastic hysteresis.
In addition, adhesion between polymers also plays a significant part in the friction between such polymers.
Yet, variances in the construction of the treatment device may hinder proper alignment or orientation of the device.
However, in this case, design or manufacturing variances may tend to produce a device where the angle between basket elements is not uniform.
This problem tends to be exacerbated after repeated actuation of the device and / or navigating the device through tortuous anatomy when the imperfections of the device become worsened through plastic deformation of the individual components.
Experience demonstrates that once a member becomes predisposed to splaying (i.e., not maintaining the desired angular separation from an adjacent element), or inverting (i.e., buckling inward instead of deploying outward), the problem is unlikely to resolve itself without requiring attention by the operator.
This interruption tends to increase the time of the treatment session.
However, the tortuous nature of the airways was found to cause significant bending and / or flexure of the distal end of the device.
For many treatment devices, the distortion of the energy transfer elements might cause variability in the treatment effect.
This directly affects the extent to which the tissue is heated.
In any number of cases, variability of the energy transfer / tissue interface causes variability in treatment results.
The consequential risks range from an ineffective treatment to the possibility of patient injury.
Therefore, distortion of the transfer element or elements increases the procedure time when the practitioner spends an inordinate amount of time adjusting a device to compensate for or avoid such distortion.
Such action becomes increasingly problematic in those cases where proper patient management limits the time available for the procedure.
For example, if a patient requires an increasing amount of medication (e.g., sedatives or anesthesia) to remain under continued control for performance of the procedure, then a medical practitioner may limit the procedure time rather than risk overmedicating the patient.
Subsequently, increasing the number of sessions poses additional consequences on the part of the patient in cost, the residual effects of any medication, adverse effects of the non-therapeutic portion of the procedure, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Energy delivery devices and methods
  • Energy delivery devices and methods
  • Energy delivery devices and methods

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0046]It is understood that the examples below discuss uses in the airways of the lungs. However, unless specifically noted, the invention is not limited to use in the lung. Instead, the invention may have applicability in various parts of the body. Moreover, the invention may be used in various procedures where the benefits of the device are desired.

[0047]FIG. 2A shows a schematic diagram of one example of a system 10 for delivering therapeutic energy to tissue of a patient for use with the device described herein. The illustrated variation shows, the system 10 having a power supply (e.g., consisting of an energy generator 12, a controller 14 coupled to the energy generator, a user interface surface 16 in communication with the controller 14). It is noted that the device may be used with a variety of systems (having the same or different components). For example, although variations of the device shall be described as RF energy delivery devices, variations of the device may include...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This relates to methods and devices for achieving contact between the wall of a cavity or passageway and a medical device when used in tortuous anatomy.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation-in-part of U.S. patent application Ser. No. 11 / 256,295, filed Oct. 21, 2005 and U.S. patent application Ser. No. 11 / 420,442, filed May 25, 2006, which is a continuation of PCT Application No. PCT / US2005 / 040378, filed Nov. 7, 2005, which claims the benefit of U.S. Provisional Patent Application Ser. Nos. 60 / 625,256, filed Nov. 5, 2004, and 60 / 650,368, filed Feb. 4, 2005, the full disclosures of which are incorporated herein by reference.BACKGROUND OF THE INVENTION[0002]Asthma is a disease in which (i) bronchoconstriction, (ii) excessive mucus production, and (iii) inflammation and swelling of airways occur, causing widespread but variable airflow obstruction thereby making it difficult for the asthma sufferer to breathe. Asthma is a chronic disorder, primarily characterized by persistent airway inflammation. However, asthma is further characterized by acute episodes of additional airway narrowing via cont...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61B17/00
CPCA61B18/1492A61B2018/00214A61B2018/00267A61N1/05A61B2018/00797A61B2018/1437A61B18/18A61B2018/00541
Inventor KAPLAN, GARY S.DANEK, CHRISTOPHER J.WIZEMAN, WILLIAM J.DALBEC, TIMOTHY R.WEBSTER, NOAHPHAN, HUY
Owner ASTHMATX
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products